Pharmacokinetic interaction of macitentan with rivaroxaban and effect of CYP3A4 induction by St. John's Wort on the steady-state pharmacokinetics of macitentan and its active metabolite in healthy volunteers

Ähnliche Einträge

• Rivaroxaban and macitentan can be coadministered without dose adjustment but the combination of rivaroxaban and St John's wort should be avoided
  von: Huppertz, Andrea, et al.
  Veröffentlicht: (2018)
• Comment on: Pharmacokinetics of the co-administration of boceprevir and St John’s wort to male and female healthy volunteers
  von: Weiß, Johanna, et al.
  Veröffentlicht: (2015)
• The effect of induction of CYP3A4 by St John's Wort on ambrisentan plasma pharmacokinetics in volunteers of known CYP2C19 genotype
  von: Markert, Christoph, et al.
  Veröffentlicht: (2015)
• Influence of St. John’s wort on the steadystate pharmacokinetics and metabolism of bosentan
  von: Markert, Christoph, et al.
  Veröffentlicht: (2014)
• Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers
  von: Brings, Antonia, et al.
  Veröffentlicht: (2019)